← All research articles

Research perspective · 2 October 2026

Less body fat does not always mean better metabolic health

What a rare genetic disorder reveals about fat storage and mitochondrial function.

This article discusses published research and an unvalidated EPK hypothesis. It reports no new experimental results.

What the research found

Human biopsies and mouse experiments linked LMNA-related lipodystrophy to disturbed lipid pathways, inflammation and regional adipocyte loss. Established human disease combined lower total fat with worse glucose and triglyceride measures. Direct respiratory impairment was demonstrated in particular mouse fat depots.

What it does not establish

This small genetic-disease study does not show that ordinary dieting produces lipodystrophy, or that additional calories treat it. Human gene-expression changes are not direct measurements of mitochondrial ATP output.

A research question for EPK

EPK should test function and fat distribution alongside mass. A useful outcome set would include strength, glucose regulation, liver fat where feasible, and regional body composition. These are proposed measurements, not demonstrated EPK benefits.

Research and guidance

Explore more studies in the research library.

  1. Maung et al. (2026). Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2. JCI 136:e198387.
  2. Companion working paper: Fuel Selection, Tissue Function and Recovery (2026), v1.0.

Related working papers

Read the relevant PDFs: EPK–001 to 007 are the revised version 1.2 papers; EPK–008 to 010 are version 1.0 supplements. Earlier PDFs and DOI records remain on the paper archive.